Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Allosteros
AddedFeb 16, 2024
UpdatedJun 18, 2026
Allosteros

Allosteros

Acquired

Allosteros Therapeutics: A California-based company pioneering in the development of small molecule drugs since 2009.

HQ
Palo Alto, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees

Allosteros Therapeutics, founded in 2009 and based in Palo Alto, California, focuses on discovering and developing breakthrough small molecule drugs. The company targets allosteric sites on key proteins involved in disease pathways, aiming to create innovative treatments for various medical conditions.

Allosteros Therapeutics has made significant strides in the pharmaceutical industry by advancing its drug development pipeline. The company's pioneering approach has attracted attention and investment, contributing to its growing impact on medical research and treatment options.

Allosteros - Similar Companies

HotSpot Therapeutics logo

HotSpot Therapeutics

hotspotthera.com

Atavistik Bio logo

Atavistik Bio

atavistikbio.com

Alsp logo

Alsp

Alcinous Pharmaceuticals logo

Alcinous Pharmaceuticals

Santi Therapeutics logo

Santi Therapeutics

Alto Neuroscience logo

Alto Neuroscience

Adrx logo

Adrx

adrxpharma.com

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Altos Labs logo

Altos Labs

altoslabs.com

Epiodyne logo

Epiodyne

Akelos logo

Akelos

akelosinc.com

Altay Therapeutics logo

Altay Therapeutics

Theracos logo

Theracos

theracos.com

AltruBio logo

AltruBio

PathDrugomics logo

PathDrugomics

Allosteros - Quick Facts

Who are Allosteros' competitors?

Companies similar to Allosteros include HotSpot Therapeutics, Atavistik Bio, Alsp and Alcinous Pharmaceuticals.

When was Allosteros founded?

Allosteros was founded in 2009.

Where is Allosteros' headquarters located?

Allosteros' headquarters is located in Palo Alto, CA, US.

When was Allosteros' last funding round?

Allosteros' most recent funding round was for $286k (USD) in August 2012.

How much has Allosteros raised to-date?

As of Aug 20, 2012, Allosteros has raised a total of $1.3M (USD).

Allosteros - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified